Fawzi Babiker

Dr. Fawzi Babiker

orcid

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 August 2013 in CardioVascular Journal of Africa
Verified
Journal Article
Open access
FBFawzi Babiker
Fawzi Babiker
LELamia A Elkhalifa
Lamia A Elkhalifa
MMMohamed E Moukhyer
Mohamed E Moukhyer
Cardiovascular Journal of Africa: Vol 24 No 6 (July 2013)

27 June 2023 in Cells
Verified
Journal Article
Open access
PDF file
MAMubeen Ahmad Ansari
Mubeen Ahmad Ansari
AAAishah A Al-Jarallah
Aishah A Al-Jarallah
FBFawzi Babiker
Fawzi Babiker
Alzheimer’s disease (AD) is a neurological condition that affects the elderly and is characterized by progressive and irreversible neurodegeneration in the cerebral cortex

1 January 2016 in American Journal of Physiology-Heart and Circulatory Physiology
Verified
Journal Article
Closed access
PDF file
AAAla'A Abwainy
Ala'A Abwainy
FBFawzi Babiker
Fawzi Babiker
SASaghir Akhtar
Saghir Akhtar
IBIbrahim F. Benter
Ibrahim F. Benter
The aim of the present study was to investigate the role of the ANG-(1–7) receptor (Mas) and nitric oxide (NO) in pacing postconditiong (PPC)-mediated cardioprotection against ischemia-reperfusion injury. Cardiac contractility and hemodynamics were assessed using a modified Langendorff system, cardiac damage was assessed by measuring infarct size and creatinine kinase levels, and levels of phosphorylated and total endothelial NO synthase (eNOS) were determined by Western blot analysis. Isolated hearts were subjected to 30 min of regional ischemia, produced by fixed position ligation of the left anterior descending coronary artery, followed by 30 min of reperfusion ( n = 6). Hearts were also subjected to PPC (three cycles of 30 s of left ventricular pacing alternated with 30 s of right atrial pacing) and/or treated during reperfusion with ANG-(1–7), NG-nitro-l-arginine methyl ester, or the Mas antagonist (d-Ala7)-ANG I/II (1–7). The PPC-mediated improvement in cardiac contractility and hemodyanamics, cardiac damage, and eNOS phosphorylation were significantly attenuated upon treatment with (d-Ala7)-ANG I/II (1–7) or NG-nitro-l-arginine methyl ester. Treatment with ANG-(1–7) improved cardiac function and reduced infarct size and creatinine kinase levels; however, the effects of ANG-(1–7) were not additive with PPC. In conclusion, these data provide novel insights into the cardioprotective mechanisms of PPC in that they involve the Mas receptor and eNOS and further suggest a potential therapeutic role for ANG-(1–7) in cardiac ischemic injury.

14 September 2013 in Journal of Physiology and Biochemistry
Verified
Journal Article
Closed access
PDF file
FBFawzi Babiker
Fawzi Babiker
SJShaji Joseph
Shaji Joseph
JJJasbir Juggi
Jasbir Juggi

5 February 2018 in Drug and Chemical Toxicology
Verified
Journal Article
Closed access
FBFawzi Babiker
Fawzi Babiker
AAAisha Al-Kouh
Aisha Al-Kouh
NKNarayana Kilarkaje
Narayana Kilarkaje
Disrupting role of lead toxicity in heart functions and prognosis of cardiovascular diseases is not well known. This study investigated the interference of lead in heart functions and pacing postconditioning-mediated protection to the heart from ischemia–reperfusion injury. Lead exposure decreased the body weight and increased the heart weight in male rats (p < 0.001). Long-term lead exposure (45 days exposure to lead) increased total oxidant levels (p < 0.001) in the heart. Furthermore, lead exposure abrogated the pacing postconditioning-mediated protection from ischemia–reperfusion injury. The latter effect showed an association with reduced total antioxidants levels (p < 0.001). In the short-term study (5 days exposure to lead), pacing postconditioning protected the heart from ischemia–reperfusion injury despite the reduced total antioxidant levels (p < 0.001). Lead toxicity caused a drastic increase in the heart weight in male rats and apoptosis. The induced oxidative stress showed association with the lack of pacing postconditioning-mediated protection of the heart. However, long-term lead exposure eliminated pacing postconditioning-mediated protection of the heart from ischemia–reperfusion injury.